Product image of Zevalin (Ibritumomab Tiuxetan) supplied by GNH India

Zevalin

Active Ingredient:
Ibritumomab Tiuxetan
Origin:
EU

Zevalin (Ibritumomab Tiuxetan)

Zevalin (ibritumomab tiuxetan) is a targeted radiotherapeutic agent used for certain types of non-Hodgkin lymphoma. This prescription medication combines immunotherapy with radioisotope delivery for precision treatment. Suitable for patients unresponsive to other therapies, it is administered under medical supervision. Seek professional guidance for suitability and dosing.

Manufacturer / TM Owner

Ceft Biopharma S.R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zevalin (ibritumomab tiuxetan) is primarily used to treat relapsed or refractory CD20-positive B-cell non-Hodgkin lymphoma, including follicular lymphoma. It may be prescribed when other treatments have not been effective. The drug targets cancer cells while sparing healthy tissue, making it a specialized option. Patients often explore this therapy after standard treatments fail.

Side Effects

  • As a radiopharmaceutical, Zevalin delivers targeted radiation to cancer cells, which may help reduce tumor size and slow disease progression. Common effects include mild fatigue or nausea during treatment, though these vary by individual. Some patients report temporary changes in blood cell counts due to bone marrow impact. Effects are typically monitored closely by healthcare providers.

Precautions & Warnings

  • Zevalin requires careful handling due to its radioactive properties; it is administered in controlled clinical settings by trained professionals. Patients should disclose full medical history, especially blood disorders or infections, before treatment. Regular blood tests are necessary to monitor safety and response. Avoid close contact with pregnant women or young children post-treatment as directed.

Avoid Interactions

  • Zevalin may interact with other medications affecting bone marrow or immune function, such as chemotherapy or immunosuppressants. Live vaccines should be avoided during and after treatment due to reduced immune response. Blood thinners or drugs impacting blood cell production may require adjustment. Always inform your healthcare provider about all medications and supplements.

Frequently Asked Questions

Zevalin is used to treat certain types of non-Hodgkin lymphoma, particularly in patients who have not responded to other therapies.

Zevalin is given as an intravenous infusion in a healthcare setting, typically over several hours.

Common effects may include fatigue, nausea, or temporary changes in blood cell counts, which are monitored by your doctor.

Zevalin is not recommended for use during pregnancy due to potential risks to the fetus; consult your healthcare provider for guidance.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ibritumomab Tiuxetan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT